These results were recently presented at the European Congress on Obesity (ECO) 2025 in Malaga, Spain
Citations: National Institute of Diabetes and Digestive and Kidney Diseases ( for general weight loss information.
Disclaimer This information is for general educational purposes only and should not be relied upon as a substitute for professional medical advice
Talk to a doctor online about Wegovy Wegovy is an exciting advancement in medicine reaching a healthier weight can help you have more energy, boost self-esteem, and reduce your risk for chronic medical conditions like cardiovascular disease, high cholesterol, and high blood pressure
GLP-1 receptor agonists like semaglutide and tirzepatide meet this standard because they address obesityrecognized as a chronic disease by the American Medical Association
Injection site reactions are purely a tirzepatide concern and have nothing to do with bupropion, but they are worth mentioning because injection site reaction treatment sometimes involves anti-inflammatory medications that could interact with other drugs in your regimen
